Lista de obras -

Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.

artículo científico publicado en 2017

Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.

artículo científico publicado en 2016

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

artículo científico publicado en 2016

Comparative proteomic profiling of sera from patients with refractory multiple myeloma reveals potential biomarkers predicting response to bortezomib-based therapy.

artículo científico publicado en 2017

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

artículo científico publicado en 2016

Exudative pericarditis in a pregnant woman as the first sign of non-Hodgkin's lymphoma.

artículo científico publicado en 2011

G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield.

artículo científico publicado en 2017

Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells

artículo científico publicado en 2020

Incidence and risk factors for central venous catheter-related thrombosis in hematological patients

artículo científico publicado en 2013

Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma

scientific article published on 19 August 2014

Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study

scientific article published on 15 August 2013

Primary breast lymphoma - a review of the literature and report of three cases

artículo científico publicado el 8 de marzo de 2011

Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group

artículo científico publicado en 2015

The necessity of post-induction therapy in mantle cell lymphoma patients: A multicenter retrospective real-world analysis by Polish Lymphoma Research Group (PLRG)

artículo científico publicado en 2019

The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.

artículo científico publicado en 2014

Thrombotic complications of central venous catheters in hematooncological patients

artículo científico publicado el 1 de enero de 2010

Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP - the PLRG report

artículo científico publicado en 2020

Lista de obras de

Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.

Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

Comparative proteomic profiling of sera from patients with refractory multiple myeloma reveals potential biomarkers predicting response to bortezomib-based therapy.

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes

Exudative pericarditis in a pregnant woman as the first sign of non-Hodgkin's lymphoma.

G-CSF mobilized peripheral blood stem cell collection for allogeneic transplantation in healthy donors: Analysis of factors affecting yield.

Hypomethylation of the promoter region drives ectopic expression of TMEM244 in Sézary cells

Incidence and risk factors for central venous catheter-related thrombosis in hematological patients

Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma

Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study

Primary breast lymphoma - a review of the literature and report of three cases

Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group

The necessity of post-induction therapy in mantle cell lymphoma patients: A multicenter retrospective real-world analysis by Polish Lymphoma Research Group (PLRG)

The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.

Thrombotic complications of central venous catheters in hematooncological patients

Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP - the PLRG report